Xem Cost-effectiveness of dapagliflozin versus sulfonylurea in combination with metformin in patients with type 2 diabetes in Vietnam: Analysis from the Payer’s Perspective

Quay trở lại Chi tiết Bài báo Cost-effectiveness of dapagliflozin versus sulfonylurea in combination with metformin in patients with type 2 diabetes in Vietnam: Analysis from the Payer’s Perspective Tải xuống Tải xuống PDF